Zhiqiang Wang, Zhibo Zhang, Yong Li, Li Sun, Dezhen Peng, Danyu Du, . . . Meixiao Zhan. (2021). Preclinical efficacy against acute myeloid leukaemia of SH1573, a novel mutant IDH2 inhibitor approved for clinical trials in China. Elsevier.
Chicago Style (17th ed.) CitationZhiqiang Wang, et al. Preclinical Efficacy Against Acute Myeloid Leukaemia of SH1573, a Novel Mutant IDH2 Inhibitor Approved for Clinical Trials in China. Elsevier, 2021.
MLA (9th ed.) CitationZhiqiang Wang, et al. Preclinical Efficacy Against Acute Myeloid Leukaemia of SH1573, a Novel Mutant IDH2 Inhibitor Approved for Clinical Trials in China. Elsevier, 2021.
Warning: These citations may not always be 100% accurate.